Alnylam Pharmaceuticals
ALNY
#867
Rank
$29.33 B
Marketcap
$219.20
Share price
1.43%
Change (1 day)
-49.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company